Discover
CAI
Caris Life Sciences, Inc.
18.75
2 x 17.53
2 x 20.25
bid
ask
+
0.93
5.22%
2 @ 06:01 AM
19.00 +0.25 (1.33%)
| Ytd | -30.50% | |
| 1y | -29.27% |
17.84
day range
19.26
14.19
52 week range
42.50
| Open | 18.09 | Prev Close | 17.82 | Low | 17.84 | High | 19.26 | Mkt Cap | 5.30B |
| Vol | 4.11M | Avg Vol | 2.68M | EPS | -2.76 | P/E | N/A | Forward P/E | 51.27 |
| Beta | N/A | Short Ratio | 4.24 | Inst. Own | 56.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 17.45 | 200-d Avg | 23.23 | 1yr Est | 27.83 |
| Income Statement | |||
| Total Revenue | 216.17M | ||
| Revenues (USD) | 216.17M | ||
| Cost of Revenue | 74.83M | ||
| Gross Profit | 141.35M | ||
| Operating Expenses | 136.02M | ||
| Research and Development Expense | 31.32M | ||
| Selling, General and Administrative Expense | 104.75M | ||
| Operating Income | 5.33M | ||
| Interest Expense | 12.81M | ||
| Income Tax Expense | -134.00K | ||
| Net Income | -510.00K | ||
| Net Income Common Stock | -510.00K | ||
| Net Income Common Stock (USD) | -510.00K | ||
| Consolidated Income | -510.00K | ||
| Earning Before Interest & Taxes (EBIT) | 12.17M | ||
| Earning Before Interest & Taxes (USD) | 12.17M | ||
| Weighted Average Shares | 282.56M | ||
| Weighted Average Shares Diluted | 282.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 821.15M | ||
| Cash and Equivalents (USD) | 821.15M | ||
| Investments | 2.32M | ||
| Investments Current | 2.32M | ||
| Trade and Non-Trade Receivables | 90.52M | ||
| Current Assets | 1.01B | ||
| Property, Plant & Equipment Net | 82.67M | ||
| Total Assets | 1.16B | ||
| Debt Current | 173.00K | ||
| Total Debt | 381.58M | ||
| Current Liabilities | 143.90M | ||
| Debt Non-Current | 381.40M | ||
| Total Liabilities | 568.90M | ||
| Accumulated Retained Earnings (Deficit) | -2.55B | ||
| Accumulated Other Comprehensive Income | 893.00K | ||
| Shareholders Equity | 593.49M | ||
| Shareholders Equity (USD) | 593.49M | ||
| Assets Non-Current | 148.21M | ||
| Total Debt (USD) | 381.58M | ||
| Goodwill and Intangible Assets | 19.34M | ||
| Inventory | 76.29M | ||
| Liabilities Non-Current | 425.00M | ||
| Trade and Non-Trade Payables | 69.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.39M | ||
| Net Cash Flow from Financing | 824.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.35M | ||
| Capital Expenditure | -10.34M | ||
| Issuance (Purchase) of Equity Shares | 920.00K | ||
| Issuance (Repayment) of Debt Securities | -40.00K | ||
| Net Cash Flow from Investing | -10.34M | ||
| Net Cash Flow from Operations | 32.88M | ||
| Effect of Exchange Rate Changes on Cash | -10.00K | ||
| Share Based Compensation | 15.87M | ||